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July 12, 2011:311–5was lacking to assess the histopathological correlation of myocar-
dial delayed enhancement in LVNC. In the present study, our
findings show that the fibrosis is the histological basis in the
delayed enhancement of compacted myocardium; however, it is
still unknown which mechanism plays the leading role in the
delayed enhancement of noncompacted myocardium.
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cardiomyopathy. Heart 2001;86:666–71.Letters to the EditorDiagnostic Criteria for
Percutaneous Coronary
Intervention-Related
Myocardial Infarction
Time for Revision?
A significant increase of cardiac biomarkers after percutaneous
coronary intervention (PCI) is commonplace and is thought to
reflect a clinically significant myocardial injury. According to the
joint European Society of Cardiology/American College of Car-
diology Foundation/American Heart Association/World Heart
Federation task force for the redefinition of myocardial infarction
(MI), increases of cardiac troponins 3 times the 99th percentile
upper reference limit (URL) are designated as percutaneous
coronary intervention (PCI)-related MI (type 4a) (1).
We read with interest the article by Lim et al. (2), who
concluded that creatine kinase-myocardial band (CK-MB) should
be the preferred biomarker when applying the current universal
definition of MI to periprocedural injury, because the arbitrary
limit of 3 times the 99th percentile URL troponin threshold might
be oversensitive and lead to over-diagnosis of MI in as many as
53% of patients (2). A similar conclusion was earlier reached by
Locca et al. (3), who reported a lack of substantial agreement
between the new universal definition and cardiovascular magnetic
resonance for the diagnosis of small-size periprocedural myocardial
damage after complex PCI (3). Although the current definition of
periprocedural injury based on the 3 times the 99th percentile
URL troponin value might, hence, be challenging, especially whenmeta-analysis of 15 studies and 7,578 patients, concluding that
troponin elevation was observed in 28.7% of patients undergoing
PCI, whereas the incidence of PCI-related MI according to the
new definition was 14.5% (4). Most importantly, any level of raised
troponin was associated with an increased risk of the composite of
all-cause death, MI, repeat target vessel PCI, and coronary artery
bypass graft surgery.
Taken together, this evidence suggests that the arbitrary limit of
3 times the 99th percentile URL troponin threshold for diagnosing
periprocedural injury might be urgently revised, because of 1) the
unsatisfactory diagnostic specificity at this low level; and 2) the
potentially inaccurate selection of the reference population for
calculating the URL (5). Therefore, a higher cut-off—such as that
suggested by Lim et al. (i.e., 40 times the 99th percentile)—should
be used for diagnosing periprocedural MI. This enhanced thresh-
old not only displays diagnostic performances comparable to that
of CK-MB, but also overcomes the use of a double-biomarker
approach (i.e., troponin and CK-MB), with a substantial econom-
ical saving. Nevertheless, the current threshold has meaningful
prognostic implications, so that patients with troponin values
between 3 and 40 times the 99th percentile are to be considered at
risk of adverse events and should be managed accordingly.
It is also noteworthy that sample stability is critical for troponin
testing. Wu et al. (6) recently observed variations in troponin I
above the analytical precision cut-off (as measured with a high-
sensitivity assay) in 17% of short-term and 33% of long-term
storage samples, suggesting that measurements are more accurate
when fresh samples are used, suggesting that the definition of the
optimal thresholds for both defining an increased risk of adverse
events and diagnosing MI after periprocedural injury should be
made preferably using fresh samples.
We are actually trapped between the Scylla of the universal
definition of MI and the Charybdis of the prognostic implications
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July 12, 2011:311–5of even minor troponin elevations (5). Maybe the time for
diagnostic criteria revision is coming.
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Reply
The apparent paradox of discrepant results of biomarker measure-
ments after percutaneous coronary intervention (PCI) has added
further confusion to our limited understanding of myocardial
injury that occurs during revascularization. In patients with com-
plex multivessel disease, this myocardial injury occurs equally
during either coronary artery bypass graft surgery or PCI despite
contemporary procedural technique (1). Myocardial injury during
PCI may be either adjacent, caused by occlusion of small side
branches during stent implantation, or downstream/distal, caused
by embolized atheroma/thrombotic material (2).
Our recent data suggest that higher levels of troponin elevation
orrelate well with creatine kinase-myocardial band (CK-MB)
levation after PCI (3), and we have previously shown that these
iomarker elevations reflect areas of myocardial infarction demon-
trable with cardiac magnetic resonance imaging (4). However, in
atients with lower levels of troponin elevation after PCI, CK-MB
s unlikely to be elevated. In these patients, there is limited
vidence of systemic inflammation and no evidence of myocardial
nfarction on magnetic resonance imaging.
When undertaking analyses of the clinical implication of these
maller troponin elevations after PCI, we should exclude the
otential bias of the higher troponin elevations, which, in my
pinion, have a clear prognostic consequence. Recently, Cavallini
t al. (5) have confirmed that smaller elevations of troponin after
CI (when CK-MB is normal) are principally a reflection of the
atient’s baseline risk profile and that the prognostic impact ismarginal. In my opinion, this particular clinical scenario of normal
CK-MB with small troponin rise would be best categorized in the
less emotive category “procedural necrosis” rather than “myocardial
infarction.”
Consequently, I agree with the recommendation of Lippi and
Cervellin that a change in the arbitrary threshold for procedural
infarction when measuring troponin after PCI would be useful.
This change in the “universal definition” may allow us to steer
safely between Scylla and Charybdis toward a better understanding
of revascularization injury and perhaps, ultimately, to the destina-
tion of abolishing it.
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“Universal Definition”
Methodology and
Conclusions Are a Concern
We congratulate Lim et al. (1) on their recent paper assessing this
area relevant to clinical practice, especially in light of sensitive
cardiac troponin (cTn) assays. However, we have important
concerns over the methodology and conclusions.
First, it seems inappropriate to use an insensitive test, late
gadolinium enhancement cardiac magnetic resonance (CMR), as a
gold standard diagnosis, to compare a sensitive test, cTn, with a
moderately sensitive test, creatine kinase-myocardial band (CK-
